Announced Tue, 21 Apr, 2026 · 17:31 IST

Reg 74(5) demat certificate filed with BSE for Q4 FY26

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹6.73

prior close

₹6.75

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-1.3% vs market

Healthcare Service Provider peers, median of 23sector+0.0%+0.0% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and in line with its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+1.3-1.3+0.0+0.0

Next day

-0.6+1.1-1.7-0.7+0.1

-0.4-0.4-0.1-2.2+1.8

+1.6+2.0-0.4-1.7+3.3

+0.9+1.9-1.0-2.1+3.0

-0.6+1.9-2.5-1.7+1.1

-10.1+3.0-13.1+2.7-12.8

15d

-12.2+2.3-14.5+3.3-15.5

-8.2+2.8-11.0+3.4-11.5

-25.9+11.9-37.8+1.1-27.0

-28.5+10.5-39.0-1.0-27.6

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gian Life Care has submitted to BSE the Regulation 74(5) certificate from its Registrar (Cameo Corporate Services) for the quarter ended March 31, 2026. The certificate confirms that all share dematerialisation requests received from depository participants during the quarter were duly confirmed to the depositories, the physical certificates were mutilated and cancelled, and the depository names were updated in the register of members within the SEBI-mandated timeline.

Likely market impact

Routine regulatory compliance filing; no material impact on shareholders or stock price.